本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

阿尔尼拉姆制药公司

304.00
+3.171.05%
盘后304.000.00000.00%19:50 EDT
成交量:60.96万
成交额:1.85亿
市值:396.38亿
市盈率:-144.88
高:306.17
开:303.80
低:297.67
收:300.83
数据加载中...
2021/08/11

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/08/09

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/08/09

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/08/03

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/03

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/08/03

重要事件披露

8-K - Current report
2021/05/21

重要事件披露

8-K - Current report
2021/04/29

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/29

重要事件披露

8-K - Current report
2021/04/12

重要事件披露

8-K - Current report
2021/02/11

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/11

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/11

重要事件披露

8-K - Current report
2021/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/01

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/11

重要事件披露

8-K - Current report